A favipiravir-induced angioedema and urticaria in a COVID-19 patient
Sign Up to like & getrecommendations! Published in 2022 at "Antiviral Therapy"
DOI: 10.1177/13596535221146226
Abstract: Although favipiravir is a promising drug for coronavirus disease 2019, some adverse effects, including skin lesions, have been reported. A 56-year-old female who was prescribed favipiravir by a filiation team following a positive severe acute… read more here.
Keywords: angioedema urticaria; induced angioedema; urticaria covid; favipiravir induced ... See more keywords